80
Participants
Start Date
February 2, 2024
Primary Completion Date
May 15, 2024
Study Completion Date
June 3, 2024
Control Group
Participants receive DS prescriptions from a physician based on current standard practices, which include biochemical markers, genetic data, and metabolic profiles.
AI-Guided Group
Participants receive DS prescriptions determined by an AI system, which considers genetic data, metabolic profiles, biochemical markers, and patient history.
Center of New Medical Technologies, Novosibirsk
Collaborators (1)
Center of New Medical Technologies
OTHER
S.LAB (SOLOWAYS)
OTHER